Vanguard Personalized Indexing Management’s scPharmaceuticals SCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-16,992
Closed -$96.3K 2053
2025
Q3
$96.3K Buy
16,992
+89
+0.5% +$456 ﹤0.01% 1824
2025
Q2
$64.4K Buy
+16,903
New +$52.5K ﹤0.01% 1793

Vanguard Personalized Indexing Management's SCPH Position: Q4 2025 in Review

Vanguard Personalized Indexing Management sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 16,992 shares — an estimated $96.3K sold.

Vanguard Personalized Indexing Management first reported a position in SCPH in Q2 2025 and held it in 2 quarters. The position peaked at $96.3K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

  • Vanguard Personalized Indexing Management reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 16,992 scPharmaceuticals shares in Q4 2025, an estimated $96.3K.
  • Vanguard Personalized Indexing Management first reported a position in scPharmaceuticals in Q2 2025 and held it in 2 quarters.
  • Vanguard Personalized Indexing Management's scPharmaceuticals position peaked at $96.3K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2025, filed 13 Feb 2026.